COUGH is the #7 most commonly reported adverse reaction for AZITHROMYCIN, manufactured by AiPing Pharmaceutical, Inc.. There are 2,030 FDA adverse event reports linking AZITHROMYCIN to COUGH. This represents approximately 2.3% of all 88,134 adverse event reports for this drug.
Patients taking AZITHROMYCIN who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH2,030 of 88,134 reports
COUGH is a less commonly reported adverse event for AZITHROMYCIN, but still significant enough to appear in the safety profile.
Other Side Effects of AZITHROMYCIN
In addition to cough, the following adverse reactions have been reported for AZITHROMYCIN:
COUGH has been reported as an adverse event in 2,030 FDA reports for AZITHROMYCIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with AZITHROMYCIN?
COUGH accounts for approximately 2.3% of all adverse event reports for AZITHROMYCIN, making it a notable side effect.
What should I do if I experience COUGH while taking AZITHROMYCIN?
If you experience cough while taking AZITHROMYCIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.